Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
129
NMPA:129
Drug Approvals
Urapidil Hydrochloride Injection
- Product Name
- 盐酸乌拉地尔注射液
- Approval Number
- 国药准字H20249052
- Approval Date
- Oct 16, 2024
NMPA
Esmolol Hydrochloride Injection
- Product Name
- 盐酸艾司洛尔注射液
- Approval Number
- 国药准字H20244395
- Approval Date
- Jul 9, 2024
NMPA
Linezolid and Glucose Injection
- Product Name
- 利奈唑胺葡萄糖注射液
- Approval Number
- 国药准字H20183528
- Approval Date
- Dec 18, 2023
NMPA
Atomoxetine Hydrochloride Oral Solution
- Product Name
- 盐酸托莫西汀口服溶液
- Approval Number
- 国药准字H20234564
- Approval Date
- Nov 28, 2023
NMPA
Linezolid and Glucose Injection
- Product Name
- 利奈唑胺葡萄糖注射液
- Approval Number
- 国药准字H20183529
- Approval Date
- Nov 22, 2023
NMPA
Calcium Gluconate and Sodium Chloride Injection
- Product Name
- 葡萄糖酸钙氯化钠注射液
- Approval Number
- 国药准字H20234337
- Approval Date
- Oct 18, 2023
NMPA
Fudosteine oral solution
- Product Name
- 福多司坦口服溶液
- Approval Number
- 国药准字H20234185
- Approval Date
- Sep 19, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found